Hemostemix Inc.

(HEM:PUR)

By |

Profile

Hemostemix Inc is a Canada based clinical-stage biotechnology company. Its principal business activity is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions. The company's technology platform for developing autologous cell therapies is for treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.

Contact Information

Website: www.hemostemix.com
Email: kmakofka@hemostemix.com
Main Phone: +1 403 340-9207
Address: 150 - 9th Avenue SW
Address 2: Suite 1049
State: AB
City / Town: Calgary
Country: CAN
Postal Code: T2P 3H9

Issuer Information

Exchange: CDX
CEO: Kyle Makofka
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.095 $ 0. (0.00%)
Last Price 0.095 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.095
Last Trade Volume 0 52 Wk Hi 0.11 52 Wk Low 0.08
Market Cap 28.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 300,741,524.00 EPS (TTM) -0.01 PE Ratio N/A Exchange TSXV